The 16th Annual Johns Hopkins Multiple Sclerosis Symposium Series - Houston

Description

Join us for an interactive, live CE-certified workshop exploring multidisciplinary strategies to enhance the diagnosis and management of MS.

DESCRIPTION
Join our panel of experts for an interactive, live CME-/CNE-certified workshop exploring multidisciplinary strategies to enhance the diagnosis and management of multiple sclerosis (MS) in the rapidly evolving treatment landscape. This event features distinct tracks for specialists and primary care providers. Topics will include early recognition and differential diagnosis, the latest insights from clinical trials and real-world data on disease-modifying treatment options, and avenues to foster collaborative care and shared decision-making. Don't miss this unique opportunity to engage directly with leaders in the field and ensure your practice remains at the forefront of advancements in MS care.

WHO SHOULD ATTEND

This activity is intended for neurologists, primary care physicians, nurse practitioners, physician assistants, and nurses, as well as other healthcare providers who manage patients with MS.

LEARNING OBJECTIVES
After attending this activity, the learner will demonstrate the ability to:

Multidisciplinary Joint Session

Evaluate strategies that support prompt differential diagnosis of MS to ensure effective
treatment initiation.
Describe current concepts of disease-modifying therapy (DMT) management for
relapsing MS, including different treatment strategies (immune reconstitution therapy and
early aggressive vs escalation approaches).
Assess the most recent efficacy and safety data on DMTs approved for relapsing and
progressive forms of MS.
Explain how to effectively integrate shared decision-making and collaborative care into MS
management plans.

Specialist Track

Identify imaging characteristics and other distinguishing clinical features that can be used
to differentiate MS from other demyelinating neurologic disorders to guide appropriate
treatment.
Select appropriate treatment, considering personalized benefit-to-risk profiles and shared
decision-making, for individual patients with MS or other demyelinating disorders.
Describe the mechanism of action and available data for investigational agents in MS.

Primary Care Track

Apply best practices in the symptomatic management in MS.
Implement strategies to provide whole-person care, beyond disease-specific
management, for those living with MS.

AGENDA

7:30 AM – 8:00 AM Registration and Breakfast
8:00 AM – 8:15 AM Introduction
8:15 AM – 10:15 AM Didactic Presentations

Getting on the Road to Early Diagnosis and Treatment
Increasing DMT Options, Increasing Complexity of Care: A Look at the Latest Data and Current Clinical Concepts
Cases in Collaborative Care: Working With Each Other and Working With Patients

10:15 AM – 10:30 AM Break
10:30 AM – 12:00 PM Break‐Out Case‐Based Sessions – Optimizing MS Care
Within Your Practice Setting
Specialist Track

A Detailed Look at Imaging to Make the Right Diagnosis and Help Monitor Over Time
Navigating Key Treatment Decision Points

Primary Care Track

Symptomatic Management of MS
Clinical Collaboration With Specialty Providers

This activity is jointly provided by the Johns Hopkins University School of Medicine, the Institute for Johns Hopkins Nursing, and Catalyst Medical Education, LLC.

This activity is supported by educational grants from Biogen,
EMD Serono, and TG Therapeutics, Inc.

ACCREDITATION STATEMENTS

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Johns Hopkins University School of Medicine and Catalyst Medical Education, LLC. The Johns Hopkins University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The Institute for Johns Hopkins Nursing is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

CREDIT DESIGNATION STATEMENTS
The Johns Hopkins University School of Medicine designates this live activity for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Statement of Contact Hours: This 4.0 contact hour educational activity is provided by The Institute for Johns Hopkins Nursing. The 4.0 contact hours will be awarded after the completion of the live activity and the submission of the final course evaluation.

POLICY ON PRESENTER AND PROVIDER DISCLOSURE
It is the policy of the Johns Hopkins School of Medicine and the Institute for Johns Hopkins Nursing that the presenter and provider globally disclose conflicts of interest. The Johns Hopkins School of Medicine OCME has established policies in place to identify and mitigate relevant conflicts of interest prior to this educational activity. Detailed disclosure will be made prior to presentation of the education.

NOTICE ABOUT OFF-LABEL USE PRESENTATIONS
The Johns Hopkins School of Medicine/16th Annual Johns Hopkins Multiple Sclerosis Symposium Series may include presentations on drugs or devices, or use of drugs or devices, that have not been approved by the Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he or she wishes to use in clinical practice.

The Johns Hopkins School of Medicine is committed to the free exchange of medical education. Inclusion of any presentation in this program, including presentations on off-label uses, does not imply an endorsement by Johns Hopkins of the uses, products, or techniques presented.

JOHNS HOPKINS STATEMENT OF RESPONSIBILITY
The Johns Hopkins School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.

COPYRIGHT
All rights reserved - The Johns Hopkins School of Medicine. No part of this program may be used or reproduced in any manner whatsoever without written permission except in the case of brief quotations embodied in articles or reviews.

COURSE FORMAT – METHOD OF PARTICIPATION
This live activity is expected to take approximately 4 hours to complete. Once the activity is completed, you must pass the post-test and complete the evaluation with attestation to receive CME credit.

PREREQUISITES FOR PARTICIPANTS
There are no prerequisites to participate in this activity.

POST-TEST
A post-test will be conducted at the conclusion of the activity. A grade of at least 70% within three attempts is needed to receive CME credit.

WHAT YOU SHOULD KNOW ABOUT GIFTS TO PHYSICIANS FROM INDUSTRY
Gift giving from the pharmaceutical, device and medical equipment industries to physicians has long been a customary practice. But when gift giving is not practiced within established ethical boundaries, the perception of conflict of interest is raised. All physicians and physicians in training should adhere to the AMA Code of Medical Ethics, Opinion 8.061, “Gifts to Physicians from Industry” which can be found under the AMA Code of Medical Ethics at https://code-medical-ethics.ama-assn.org/ethics-opinions/gifts-physicians-industry.

Johns Hopkins faculty, staff, employees, students, and trainees must adhere to the more restrictive Johns Hopkins Medicine Policy on Interaction with Industry that can be found at this link https://industryinteraction.jhu.edu/jhm-policy-on-interaction-with-industry.

DISCLAIMER STATEMENT
The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This live activity is produced for educational purposes only. Use of the Johns Hopkins University School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings, and adverse effects before administering pharmacologic therapy to patients.

AMERICANS WITH DISABILITIES ACT
The Johns Hopkins School of Medicine fully complies with the legal requirements of the ADA and the rules and regulations thereof. Please notify us if you have any special needs.

FULL DISCLOSURE POLICY AFFECTING CME ACTIVITIES
As a provider approved by the Accreditation Council for Continuing Medical Education (ACCME), Johns Hopkins University School of Medicine Office of Continuing Medical Education (OCME) requires attested and signed global disclosure of the existence of all financial interests or relationships with ineligible companies from any individual in a position to control the content of a CME activity sponsored by OCME.

The following relationships have been reported for this activity:

NAME - Lisa Fox, PA-C
ROLE - Presenter
COMPANY RELATIONSHIP(S)
Consulting Fee - Biogen Idec, Novartis AG, Genentech, Inc., Horizon, EMD Serono
Honoraria - National MS Society, Catalyst Medical Education, LLC

NAME - Scott Newsome, MD, MSCS, FAAN, FANA
ROLE - Activity Director/Presenter
COMPANY RELATIONSHIP(S)
Consulting Fee - Biogen Idec, Genentech, Inc., Novartis AG, Bristol-Myers Squib Aventis, EMD Serono, Horizon Therapeutics
Advisor - Roche
Grant or Research Support - Biogen Idec, Roche, Genentech, Inc., National MS Society, Department of Defense, PCORI, The Stiff Person Syndrome Research Foundation, Lundbeck

NAME - Andrew Solomon, MD
ROLE - Presenter
COMPANY RELATIONSHIP(S)
Grant or Research Support - Bristol-Myers Squibb
Consulting Fee - Kiniksa Pharmaceuticals
Advisor - Horizon Therapeutics
Paid consultant - EMD Serono

No one else in a position to control the content of this educational activity has disclosed a relevant financial interest or relationship with ineligible companies. All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

CONFIDENTIALITY DISCLAIMER FOR CME ACTIVITY PARTICIPANTS
I certify that I am participating in a Johns Hopkins University School of Medicine CME activity for accredited training and/or educational purposes.

I understand that while I am participating in this capacity, I may be exposed to "protected health information," as that term is defined and used in Hopkins policies and in the federal HIPAA privacy regulations (the Privacy Regulations). Protected health information is information about a person's health or treatment that identifies the person.

I pledge and agree to use and disclose any of this protected health information only for the training and/or educational purposes of my visit and to keep the information confidential. I agree not to post or discuss this protected health information, including pictures and/or videos on any social medial site (e.g. Facebook, Twitter, etc.), in any electronic messaging program or through any portable electronic device.

I understand that I may direct to the Johns Hopkins Privacy Officer any questions I have about my obligations under this Confidentiality Pledge or under any of the Hopkins policies and procedures and applicable laws and regulations related to confidentiality. The contact information is Johns Hopkins Privacy Officer, telephone: 410-735-6509, e-mail:@HIPAA@jhmi.edu.

"The Office of Continuing Medical Education at The Johns Hopkins University School of Medicine, as provider of this activity, has relayed information with the CME attendees/participants and certifies that the visitor is attending for training, education and/or observation purposes only."

For CME questions, please contact the CME Office (410) 955-2959 or e-mail @cmenet@jhmi.edu. For certificates, please call (410) 502-9636.

Johns Hopkins University School of Medicine Office of Continuing Medical Education
Turner 20/720 Rutland Avenue
Baltimore, Maryland 21205-2195

Reviewed & Approved by:
General Counsel, Johns Hopkins Medicine (4/1/03)
(Updated 4/09 and 3/14)